SELL Alert: This FDA Approval is Not What It Seems

Posted On Jan 18, 2017 By Ray Blanco

The FDA’s decision on this company’s abuse-resistant drug makes it a sell…


Subscribe to AGORA Financial’s FDA Trader Today!

Agora Financial’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market.

Subscribe Today!